Variables | Diabetic patients (N = 30) | Controls (N = 30) | |
---|---|---|---|
Before lactoferrin | After lactoferrin | ||
Age | 12–17 | 11 ± 17 | |
Gender | |||
Male/female | 34/26 | 28/22 | |
BMI (kg/m2) | 30.9 ± 2.5a | 28.8 ± 2.1 | 21.2 ± 1.2 |
Lactoferrin (ng/mL) | |||
Range | 25.6–35.5 | 44.2–60.5 | 9.7–19.1 |
Mean ± SD | 29.73 ± 4.05a | 52.35 ± 6.75b | 14.01 ± 3.00 |
FPG (mg/dL) | |||
Range | 197–269a | 131–189b | 67–110 |
Mean ± SD | 233 ± 36 | 130 ± 29 | 87 ± 22 |
HbA1c (%) | 9.8 ± 1.3a | 7.2 ± 1b | 5.3 ± 1.5 |
Insulin range | 2.87–14.4a | 24.5–35.6b | 7.3–10.3 |
Total cholesterol (mg/dL) | 240.5 ± 13.2a | 170.6 ± 11.2b | 110.67 ± 9.2 |
Triglycerides (mg/dL) | 183.4 ± 6.5a | 131 ± 10.2b | 75.23 ± 0.92 |
HDL-C (mg/dL) | 27.4 ± 3.5a | 38.5 ± 3.3b | 42.87 ± 3.2 |
LDL-C (mg/dL) | 176.5 ± 12.5a | 105.9 ± 8.2b | 53.2 ± 3.2 |